BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 25310727)

  • 1. Alteration of epithelial-mesenchymal transition markers in human normal ovaries and neoplastic ovarian cancers.
    Yi BR; Kim TH; Kim YS; Choi KC
    Int J Oncol; 2015 Jan; 46(1):272-80. PubMed ID: 25310727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistological insight into the correlation between neuropilin-1 and epithelial-mesenchymal transition markers in epithelial ovarian cancer.
    Adham SA; Al Harrasi I; Al Haddabi I; Al Rashdi A; Al Sinawi S; Al Maniri A; Ba-Omar T; Coomber BL
    J Histochem Cytochem; 2014 Sep; 62(9):619-31. PubMed ID: 24850663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal-to-epithelial transition determinants as characteristics of ovarian carcinoma effusions.
    Elloul S; Vaksman O; Stavnes HT; Trope CG; Davidson B; Reich R
    Clin Exp Metastasis; 2010 Mar; 27(3):161-72. PubMed ID: 20213325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia promotes vasculogenic mimicry formation by inducing epithelial-mesenchymal transition in ovarian carcinoma.
    Du J; Sun B; Zhao X; Gu Q; Dong X; Mo J; Sun T; Wang J; Sun R; Liu Y
    Gynecol Oncol; 2014 Jun; 133(3):575-83. PubMed ID: 24589413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of epithelial-mesenchymal transition-related markers between cancer tissue and tumor emboli].
    He N; Wu GF; Zhao HY; Han HX
    Zhonghua Bing Li Xue Za Zhi; 2011 Nov; 40(11):758-61. PubMed ID: 22336160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vimentin expression is associated with decreased survival in gastric cancer.
    Otsuki S; Inokuchi M; Enjoji M; Ishikawa T; Takagi Y; Kato K; Yamada H; Kojima K; Sugihara K
    Oncol Rep; 2011 May; 25(5):1235-42. PubMed ID: 21327330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial-mesenchymal transition in ovarian cancer progression: a crucial role for the endothelin axis.
    Bagnato A; Rosanò L
    Cells Tissues Organs; 2007; 185(1-3):85-94. PubMed ID: 17587812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bisphenol A and nonylphenol have the potential to stimulate the migration of ovarian cancer cells by inducing epithelial-mesenchymal transition via an estrogen receptor dependent pathway.
    Kim YS; Hwang KA; Hyun SH; Nam KH; Lee CK; Choi KC
    Chem Res Toxicol; 2015 Apr; 28(4):662-71. PubMed ID: 25690688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Epithelial-Mesenchymal Transition, E-cadherin and Tumor Progression in Ovarian Serous Tumors.
    Bozhkova DM; Poryazova-Markova EG
    Folia Med (Plovdiv); 2019 Jun; 61(2):296-302. PubMed ID: 31301662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Putative stem cells and epithelial-mesenchymal transition revealed in sections of ovarian tumor in patients with serous ovarian carcinoma using immunohistochemistry for vimentin and pluripotency-related markers.
    Kenda Suster N; Smrkolj S; Virant-Klun I
    J Ovarian Res; 2017 Feb; 10(1):11. PubMed ID: 28231820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquisition of chemoresistance and EMT phenotype is linked with activation of the endothelin A receptor pathway in ovarian carcinoma cells.
    Rosanò L; Cianfrocca R; Spinella F; Di Castro V; Nicotra MR; Lucidi A; Ferrandina G; Natali PG; Bagnato A
    Clin Cancer Res; 2011 Apr; 17(8):2350-60. PubMed ID: 21220476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic plasticity of the ovarian surface epithelium: TGF-beta 1 induction of epithelial to mesenchymal transition (EMT) in vitro.
    Zhu Y; Nilsson M; Sundfeldt K
    Endocrinology; 2010 Nov; 151(11):5497-505. PubMed ID: 20844000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genistein suppressed epithelial-mesenchymal transition and migration efficacies of BG-1 ovarian cancer cells activated by estrogenic chemicals via estrogen receptor pathway and downregulation of TGF-β signaling pathway.
    Kim YS; Choi KC; Hwang KA
    Phytomedicine; 2015 Oct; 22(11):993-9. PubMed ID: 26407941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of the genetic and the immunohistochemical expression of epithelial-mesenchymal-related markers in colon cancer.
    Rashed HE; Hussein S; Mosaad H; Abdelwahab MM; Abdelhamid MI; Mohamed SY; Mohamed AM; Fayed A
    Cancer Biomark; 2017 Jul; 20(1):107-122. PubMed ID: 28759954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p70 S6 kinase promotes epithelial to mesenchymal transition through snail induction in ovarian cancer cells.
    Pon YL; Zhou HY; Cheung AN; Ngan HY; Wong AS
    Cancer Res; 2008 Aug; 68(16):6524-32. PubMed ID: 18701475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human chorionic gonadotropin β regulates epithelial-mesenchymal transition and metastasis in human ovarian cancer.
    Liu N; Peng SM; Zhan GX; Yu J; Wu WM; Gao H; Li XF; Guo XQ
    Oncol Rep; 2017 Sep; 38(3):1464-1472. PubMed ID: 28713970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial-mesenchymal transition markers in malignant ovarian germ cell tumors.
    Solheim O; Førsund M; Tropé CG; Kraggerud SM; Nesland JM; Davidson B
    APMIS; 2017 Sep; 125(9):781-786. PubMed ID: 28585395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2.
    Chao A; Lin CY; Lee YS; Tsai CL; Wei PC; Hsueh S; Wu TI; Tsai CN; Wang CJ; Chao AS; Wang TH; Lai CH
    Oncogene; 2012 Feb; 31(6):764-75. PubMed ID: 21725366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial-mesenchymal transition increases during the progression of in situ to invasive basal-like breast cancer.
    Choi Y; Lee HJ; Jang MH; Gwak JM; Lee KS; Kim EJ; Kim HJ; Lee HE; Park SY
    Hum Pathol; 2013 Nov; 44(11):2581-9. PubMed ID: 24055090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical study of the epithelial-mesenchymal transition phenotype in cancer of unknown primary: incidence, correlations and prognostic utility.
    Stoyianni A; Goussia A; Pentheroudakis G; Siozopoulou V; Ioachim E; Krikelis D; Golfinopoulos V; Cervantes A; Bobos M; Fotsis T; Bellou S; Fountzilas G; Malamou-Mitsi V; Pavlidis N
    Anticancer Res; 2012 Apr; 32(4):1273-81. PubMed ID: 22493359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.